Cancer patients, clinicians find value in electronic real-time symptom reporting system

Both cancer patients and their medical teams found it beneficial when patients shared their symptoms in real time using a web- or telephone-based reporting system, according to a national multi-institutional study. Ethan Basch, MD, MSc, at the University of North Carolina Lineberger Comprehensive Cancer Center, and his colleagues reported in the journal JCO Clinical Cancer […]

Continue Reading

Melding biology and physical sciences yields deeper understanding of cancer

An evolving understanding of cancer that incorporates the physical properties of tumors and their surrounding tissues into existing biologic and genetic models can direct cancer researchers down previously uncharted avenues, potentially leading to new drugs and new treatment strategies, say investigators from Massachusetts General Hospital (MGH), Harvard Medical School (HMS) and the Ludwig Center at […]

Continue Reading

For Black LGBQ+ Americans, intersectional experiences can hurt—or help, YSPH study finds

For Black LGBQ+ Americans, Intersectional Experiences Can Hurt—Or Help, YSPH Study FindsUsing a new method for quantifying intersectional experiences, a new Yale School of Public Health study finds that Black LGBQ+ Americans tend to feel better about themselves after encountering events that affirm their identity. In the study, which was recently published in the Journal […]

Continue Reading

Children with asymptomatic brain bleeds as newborns show normal brain development at age 2

In 2007, UNC researchers published unexpected and surprising results from a study based on magnetic resonance imaging (MRI) of newborn brains. Twenty-six percent of the newborns in the study were found to have asymptomatic subdural hemorrhages, or bleeding in and around the brain. It was an unexpected finding because subdural hemorrhage had been considered unusual […]

Continue Reading

Wistar creates a new synthetic DNA vaccine against Powassan virus

Scientists at The Wistar Institute have designed and tested the first-of-its-kind synthetic DNA vaccine against Powassan virus (POWV), targeting portions of the virus envelope protein. A rapidly reemerging tick-borne disease, POWV has been reported to be fatal in 10% of infected people with detrimental neurological consequences including encephalitis and meningitis. This new POWV vaccine candidate, […]

Continue Reading